Histogen to resume trading at 4:35 pm ET
PremiumThe FlyHistogen to resume trading at 4:35 pm ET
1y ago
Histogen Board adopts Plan of Dissolution, including distribution of cash
Premium
The Fly
Histogen Board adopts Plan of Dissolution, including distribution of cash
1y ago
Histogen Announces Board Approval of Complete Liquidation and Dissolution
Premium
Press Releases
Histogen Announces Board Approval of Complete Liquidation and Dissolution
1y ago
Histogen trading halted, news pending
PremiumThe FlyHistogen trading halted, news pending
1y ago
Histogen Reports First Quarter 2023 Results and Provides Business Update
Premium
Press Releases
Histogen Reports First Quarter 2023 Results and Provides Business Update
1y ago
Histogen Announces Online Publication in the Journal of Investigative Dermatology
Premium
Press Releases
Histogen Announces Online Publication in the Journal of Investigative Dermatology
1y ago
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
PremiumPress ReleasesHistogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
2y ago
Histogen price target lowered to $2.00 from $5.00 at Canaccord
Premium
The Fly
Histogen price target lowered to $2.00 from $5.00 at Canaccord
2y ago
Histogen Reports Year-End 2022 Results and Provides Business Update
Premium
Press Releases
Histogen Reports Year-End 2022 Results and Provides Business Update
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100